Tag Archives: Breaking News: Markets

Gilead Sciences, Starbucks, BP, Coty and more

Take a look at some of the most important engines on the previous market: Gilead Sciences (GILD) – Gilead priced its Covid-19 antiviral treatment remdesivir, with developed world governments paying $ 390 per dose and privately insured patients charging $ 520 per dose. Intercept Pharmaceuticals (ICPT): The Food and Drug …

Read More »